Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

Presenter: David Erlinge

October 28, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Presenter: David Erlinge

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Presentation TCT 2024

Overview of Latest Clinical Evidence

Presenter: David Erlinge

October 30, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

Presenter: Elmir Omerovic

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Presenter: David Erlinge

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

Presentation TCT 2023

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

Presenter: Matthias Götberg

October 25, 2023

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2021

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Presenter: Matthias Götberg

November 04, 2021

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

Presentation TCT 2019

Resting Indices vs. Hyperemic Evaluation of Physiology in ACS: What Did We Learn From DEFINE-FLAIR and Swedeheart?

Presenter: Christopher Cook

September 27, 2019

Presentation TCT 2019

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

Presenter: Matthias Götberg

September 27, 2019

Presentation TCT 2018

TAKOTSUBO (SWEDEHEART): Effects of Pharmacological Interventions on Mortality in Patients With Takotsubo Syndrome

Presenter: John A. Bittl, Bernard J. Gersh, Elmir Omerovic

September 24, 2018

Presentation TCT 2018

iFR-SWEDEHEART: Two-Year Follow-up From a Randomized Trial of Instantaneous Wave-Free Ratio vs Fractional Flow Reserve Guided PCI

Presenter: Nick Curzen, Nils Johnson, Ole Fröbert

September 22, 2018

Presentation TCT 2017

DEFINE FLAIR/SWEDEHEART: Critique and Unanswered Questions

Presenter: David J. Cohen, Ajay J. Kirtane, Habib Samady

November 01, 2017

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

What’s Going to Be Hot at TCT 2025

Overview of Latest Clinical Evidence

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

What’s Going to Be Big at TCT 2024?

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Resting Indices vs. Hyperemic Evaluation of Physiology in ACS: What Did We Learn From DEFINE-FLAIR and Swedeheart?

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

TAKOTSUBO (SWEDEHEART): Effects of Pharmacological Interventions on Mortality in Patients With Takotsubo Syndrome

iFR-SWEDEHEART: Two-Year Follow-up From a Randomized Trial of Instantaneous Wave-Free Ratio vs Fractional Flow Reserve Guided PCI

DEFINE FLAIR/SWEDEHEART: Critique and Unanswered Questions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content